BioSpace News Archive

Compugen Ltd., a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced that management will present at the 11th Annual SVB Leerink Global Healthcare Conference, on Wednesday, February 16, 2022 at 12:00 pm ET.

Medovate has announced that it has entered into an agreement with Mercury Medical for exclusive distribution of the FDA-cleared device SAFIRA.

Hoth Therapeutics, Inc. today announced it has signed an agreement with NUVISAN, a European CRO/CDMO with topical manufacturing capabilities in Sophia-Antipolis, France , to manufacture clinical batches of HT-001.

The aberrant Trop-2 overexpression is associated in several solid tumors including colorectal, lung cancer, and breast cancers.

The mitogen activated protein kinase (MAPK) signaling pathway or Ras/Raf/MEK/ERK pathway is one of the critical pathways involved in signal transduction, which results in the control of cell proliferation, survival, and differentiation

REGENXBIO Inc. announced additional positive interim data from Cohorts 1-3 of the ongoing Phase I/II trial of RGX-121 for the treatment of patients up to 5 years old diagnosed with Mucopolysaccharidosis Type II, also known as Hunter Syndrome, are being presented at the 18th Annual WORLDSymposium™.

The Board of Directors of Sartorius Stedim Biotech S.A. resolved at today’s meeting to submit a proposal to the combined Annual General Shareholders’ Meeting (AGM) on March 29, 2022 , to pay a dividend of 1.26 euros per share for fiscal 2021, up from 0.68 euros per share a year earlier.

The report provides details about market size, market restraints, drivers, challenges, growth opportunities, and top companies in the market.

REGENXBIO Inc. today announced positive interim data are being presented at the 18th Annual WORLDSymposium™ from five patients in the ongoing Phase I/II trial and one patient from a single-patient Investigational New Drug (IND) application of RGX-111 for the treatment of severe Mucopolysaccharidosis Type I (MPS I).

The report also highlights about changes in the market dynamics due to outbreak of the COVID-19 pandemic.